Cardiff Oncology, Inc. (NASDAQ:CRDF) Financings

Cardiff Oncology, Inc.

Financings

RaiseDate
Registered direct offering of common stock and warrants
Closed: US$10M raised · US$1.05 a share · ½ warrant at US$1.31 for 66 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: Certain officers and directors (731,707 shares and accompanying warrants at $1.435 per share and accompanying warrant)
Insiders: Certain officers and directors are buying 731,707 shares and accompanying warrants at $1.435 per share and accompanying warrant
Use of proceeds: Working capital and general corporate purposes
Aug 11, 2026

Read by 6ix AI from the company's releases